Global Executive Summary Preimplantation Genetic Screening (PGS) Technology Market: Size, Share, and Forecast
Data Bridge Market Research analyses that the preimplantation genetic screening (PGS) technology market which was USD 552.50 million in 2021, would rocket up to USD 1228.09 million by 2029, and is expected to undergo a CAGR of 10.50% during the forecast period 2022 to 2029.
The report has provided crucial information about the elements that are impacting and driving the sales of the Preimplantation Genetic Screening (PGS) Technology Market. The section of the competitive landscape keeps utmost importance in the report which consists of key market players functioning in the worldwide Preimplantation Genetic Screening (PGS) Technology Market industry. The market analysis report has been formulated with the proper research methodology and validated from the professionals and analysts to ensure the eminent quality reports. According to this Preimplantation Genetic Screening (PGS) Technology Market report, several macroeconomic factors, such as gross domestic product (GDP) and the increasing inflation rate, are expected to affect directly or indirectly in the development of the market.
Preimplantation Genetic Screening (PGS) Technology is a professional and comprehensive report covering market parameters about the Preimplantation Genetic Screening (PGS) Technology Market industry. The report pinpoints on the leading market competitors with explaining company profile depending on SWOT analysis to illustrate the competitive nature of the market internationally. Even more, the report comprises of market evolution, market shares, associations and level of investments with other leading companies, monetary settlements impacting the Preimplantation Genetic Screening (PGS) Technology Market in recent years are also analysed. This global industry analysis report endows with the insights about import/export consumption, supply and demand figures, cost, price, revenue and gross margins.
Stay ahead with crucial trends and expert analysis in the latest Preimplantation Genetic Screening (PGS) Technology Market report.
Download now:
https://www.databridgemarketresearch.com/reports/global-preimplantation-genetic-screening-pgs-technology-market
Preimplantation Genetic Screening (PGS) Technology Industry Overview
Segments
- By Procedure Type
- Preimplantation Genetic Diagnosis
- Preimplantation Genetic Screening
- By Technology Platform
- Next-Generation Sequencing
- Fluorescent In-Situ Hybridization
- Comparative Genomic Hybridization
- Single-Nucleotide Polymorphism
- Other Technologies
- By End-User
- Fertility Clinics
- Hospitals
- Clinical R&D Laboratories
Preimplantation Genetic Screening (PGS) technology is witnessing significant growth, primarily driven by the increasing demand for advanced technologies in genetic screening and the rising prevalence of genetic disorders. The market is segmented based on procedure type, technology platform, and end-user. By procedure type, the market is divided into preimplantation genetic diagnosis and preimplantation genetic screening. Preimplantation genetic screening is expected to dominate the market due to its applications in identifying chromosomal abnormalities in embryos before implantation. The technology platform segment includes next-generation sequencing, fluorescent in-situ hybridization, comparative genomic hybridization, single-nucleotide polymorphism, and other technologies. Next-generation sequencing is anticipated to hold a significant market share owing to its high efficiency and accuracy in screening genetic abnormalities. Fertility clinics, hospitals, and clinical R&D laboratories are the key end-users of PGS technology, with fertility clinics being the major contributors to market revenue.
Market Players
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- Abbott
- Agilent Technologies, Inc.
- CooperSurgical, Inc.
- F. Hoffmann-La Roche Ltd
- Natera, Inc.
- Oxford Gene Technology
- Yikon Genomics
Key market players in the global preimplantation genetic screening (PGS) technology market include Illumina, Inc., Thermo Fisher Scientific Inc., PerkinElmer Inc., Abbott, Agilent Technologies, Inc., CooperSurgical, Inc., F. Hoffmann-La Roche Ltd, Natera, Inc., Oxford Gene Technology, and Yikon Genomics. These companies focus on strategic initiatives such as partnerships, collaborations, product launches, and acquisitions to strengthen their market position. The market is competitive, with players investing in research and development activities to launch innovative products and gain a competitive edge in the global PGS technology market.
The global preimplantation genetic screening (PGS) technology market is poised for significant growth in the coming years, driven by several key factors. One of the primary growth drivers is the increasing awareness and adoption of advanced genetic screening technologies to identify genetic abnormalities in embryos before implantation. This trend is particularly prevalent in developed regions where there is a higher prevalence of genetic disorders and a growing emphasis on personalized healthcare. Additionally, the rising demand for assisted reproduction techniques, coupled with advancements in genetic testing technologies, is expected to further fuel market growth.
In terms of market segmentation, the PGS technology market can be analyzed based on procedure type, technology platform, and end-user. Preimplantation genetic screening, a procedure aimed at identifying chromosomal abnormalities in embryos, is expected to dominate the market due to its wide range of applications and benefits in improving the success rates of assisted reproductive procedures. Among the various technology platforms available for PGS, next-generation sequencing stands out as a key player, offering high efficiency and accuracy in genetic screening processes. Other technologies such as fluorescent in-situ hybridization, comparative genomic hybridization, and single-nucleotide polymorphism also play crucial roles in enhancing the efficacy of genetic screening.
End-users of PGS technology include fertility clinics, hospitals, and clinical R&D laboratories. Fertility clinics are projected to be the major contributors to market revenue, given their role in providing assisted reproductive services that often incorporate genetic screening technologies. Hospitals and clinical R&D laboratories also play significant roles in the adoption and utilization of PGS technology, contributing to the overall market growth. The increasing collaboration and partnerships between technology providers and end-users are further expected to propel market expansion and foster innovation in the field.
Key market players in the global PGS technology market are actively engaged in strategic initiatives to strengthen their market position. Partnerships, collaborations, product launches, and acquisitions are commonly employed strategies to enhance product portfolios, expand market reach, and cater to evolving customer needs. The competitive landscape of the market encourages investment in research and development activities to launch innovative products that offer superior performance and accuracy in genetic screening. Overall, the global PGS technology market is set to witness robust growth, driven by technological advancements, increasing demand for genetic screening, and strategic efforts by market players to stay ahead in this dynamic and evolving industry landscape.The global preimplantation genetic screening (PGS) technology market is experiencing significant growth propelled by a combination of factors driving demand for advanced genetic screening solutions. One of the primary growth drivers is the increasing awareness and adoption of genetic screening technologies to detect genetic abnormalities in embryos before implantation. This surge in demand is particularly prominent in developed regions with a higher prevalence of genetic disorders and a growing focus on personalized healthcare. Moreover, the escalating need for assisted reproduction techniques along with continuous advancements in genetic testing technologies is expected to further boost market expansion.
Segment-wise, the market for PGS technology can be categorized based on procedure type, technology platform, and end-user. Preimplantation genetic screening, aimed at detecting chromosomal abnormalities in embryos, is poised to lead the market due to its versatile applications and positive impact on the success rates of assisted reproductive procedures. Among the technology platforms available for PGS, next-generation sequencing emerges as a pivotal player offering superior efficiency and accuracy in genetic screening processes. Complementary technologies like fluorescent in-situ hybridization, comparative genomic hybridization, and single-nucleotide polymorphism also contribute significantly to enhancing the effectiveness of genetic screening methods.
End-users of PGS technology encompass fertility clinics, hospitals, and clinical R&D laboratories. Fertility clinics are expected to make substantial contributions to market revenue, given their pivotal role in providing assisted reproductive services integrating genetic screening technologies. Hospitals and clinical R&D laboratories also play crucial roles in fostering the adoption and utilization of PGS technology, thereby contributing to overall market growth. The increasing collaborations and partnerships between technology providers and end-users are projected to drive market expansion, stimulate innovation, and further solidify the industry landscape.
Key market players in the global PGS technology market are actively pursuing strategic initiatives to fortify their market presence. Partnerships, collaborations, product launches, and acquisitions are common strategies employed to enrich product portfolios, expand market outreach, and cater to evolving customer requirements. The competitive nature of the market incentivizes investments in research and development endeavors to introduce innovative products that deliver enhanced performance and accuracy in genetic screening processes. Overall, the global PGS technology market is positioned for robust growth driven by technological advancements, escalating demand for genetic screening solutions, and the proactive efforts of market participants to maintain a competitive edge in a dynamic and evolving industry environment.
Access detailed insights into the company’s market position
https://www.databridgemarketresearch.com/reports/global-preimplantation-genetic-screening-pgs-technology-market/companies
Alternative Research Questions for Global Preimplantation Genetic Screening (PGS) Technology Market Analysis
- What is the current valuation of the global Preimplantation Genetic Screening (PGS) Technology Market?
- What CAGR is projected for the Preimplantation Genetic Screening (PGS) Technology Market over the forecast period?
- What are the key segments analyzed in the Preimplantation Genetic Screening (PGS) Technology Market report?
- Which companies dominate the Preimplantation Genetic Screening (PGS) Technology Market landscape?
- What geographic data is covered in the Preimplantation Genetic Screening (PGS) Technology Market analysis?
- Who are the leading firms operating in the Preimplantation Genetic Screening (PGS) Technology Market?
Browse More Reports:
Global Immuno In-Vitro Diagnostics (IVD) Market
Global Kraft Paper Market
Global Okra Snacks Market
Global Pandan Tea Market
Global Space Tourism Market
U.S. and Mexico Cat Litter Market
Asia-Pacific Cocoa Products Market
Brazil Hearing Aids Market
Global Biocatalysts Market
Global Clinical Trial Market
Global Corn Meal Market
Global Fruit Spreads Market
Global Functional Beverages Market
Global Goat Milk Yogurt Market
Global L-Theanine Market
About Data Bridge Market Research:
An absolute way to forecast what the future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
Email:- corporatesales@databridgemarketresearch.com
"
Comments
Post a Comment